JMJean‐Marie Matthieu

Jean‐Marie Matthieu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jean‐Marie Matthieu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Cécile Besson Duvanel

    Neurochemistry Laboratory, Department of Pediatrics, CHUV, Lausanne, Switzerland

    2 shared publications
  • Paul Honegger

    Institute of Physiology, University of Lausanne, Lausanne, Switzerland

    2 shared publications
  • Douglas Feinstein

    Department of Anesthesiology, University of Illinois, Chicago, Illinois

    1 shared publication
  • Harrihar Pershadsingh

    Department of Family Medicine, Kern Medical Center and UC Irvine, Irvine, California

    1 shared publication

Latest Publications

  • Inhibition of glial cell proinflammatory activities by peroxisome proliferator‐activated receptor gamma agonist confers partial protection during antimyelin oligodendrocyte glycoprotein demyelination in vitro

    by Cécile Besson Duvanel, Paul Honegger, Harrihar Pershadsingh, Douglas Feinstein, Jean‐Marie Matthieu

    Peroxisome proliferator‐activated receptor gamma (PPAR‐γ) is a member of the nuclear hormone superfamily originally characterized as a regulator of adipocyte differentiation and lipid metabolism. In addition, PPAR‐γ has important immunomodulatory functions. If the effect of PPAR‐γ's activation in T‐cell‐mediated demyelination has been recently demonstrated, nothing is known about the role of PPAR‐γ in antibody‐induced demyelination in the absence of T‐cell interactions and monocyte/macrophage activation. Therefore, we investigated PPAR‐γ's involvement by using an in vitro model of inflammatory demyelination in three‐dimensional aggregating rat brain cell cultures. We found that PPAR‐γ was not constitutively expressed in these cultures but was strongly up‐regulated following demyelination mediated by antibodies directed against myelin oligodendrocyte glycoprotein (MOG) in the presence of complement. Pioglitazone, a selective PPAR‐γ agonist, partially protected aggregates from anti‐MOG demyelination. Heat shock responses and the expression of the proinflammatory cytokine tumor necrosis factor‐α were diminished by pioglitazone treatment. Therefore, pioglitazone protection seems to be linked to an inhibition of glial cell proinflammatory activities following anti‐MOG induced demyelination. We show that PPAR‐γ agonists act not only on T cells but also on antibody‐mediated demyelination. This may represent a significant benefit in treating multiple sclerosis patients.


  • Retracted

    Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures

    by Cécile Besson Duvanel, Paul Honegger, Jean‐Marie Matthieu

    To link the presence of intrathecal virus‐specific oligoclonal immunoglobulin G (IgG) in multiple sclerosis patients to a demyelinating activity, aggregating rat brain cell cultures were treated with antibodies directed against two viruses, namely, rubella (RV) and hepatitis B (HB). Anti‐RV antibodies in the presence of complement decreased myelin basic protein concentrations in a dose‐dependent manner, whereas anti‐HB antibodies had no effect. A similar but less pronounced effect was observed on the enzymatic activity of 2′,3′‐cyclic nucleotide 3′‐phosphohydrolase, which is enriched in noncompact membranes of oligodendrocytes. These effects were comparable to those in cultures treated with antibodies directed against myelin oligodendrocyte glycoprotein (MOG), previously found to be myelinotoxic both in vitro and in vivo. Sequence homologies were found between structural glycoprotein E2 of RV and MOG, suggesting that demyelination was due to molecular mimicry. To support the hypothesis that demyelination was caused by anti‐RV IgG that recognized an MOG epitope, we found that anti‐RV antibodies depleted MOG in a dose‐dependent manner. Further evidence came from the demonstration that anti‐RV and anti‐MOG IgG colocalized on oligodendrocyte processes and that both revealed by Western blot a 28 kDa protein in CNS myelin, a molecular weight corresponding to MOG. These findings suggest that a virus such as RV exhibiting molecular mimicry with MOG can trigger an autoimmune demyelination. J. Neurosci. Res. 65:446–454, 2001.